Galectin Therapeutics (NASDAQ: GALT) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company’s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function.

Pharmaceutical

Galectin Therapeutics

Galectin Therapeutics' headquarters in Norcross, GA, United States

Joel Lewis

Khurram Jamil

Beth Knowles

Marla Mills-Wilson

Jack W. Callicutt

Gilbert F. Amelio

Richard E. Uihlein

James C. Czirr

Kary Eldred

Kevin D. Freeman

Elissa J. Schwartz

Marc Rubin

Gilbert S. Omenn

Harold H. Shlevin

Richard A. Zordani

The Independent Directors at Galectin Therapeutics provide unbiased governance and oversight, ensuring the company adheres to regulatory standards and sound ethical practices. They leverage their diverse expertise to guide strategic decisions, mitigate risks, and safeguard shareholder interests in the development of innovative therapies for fibrotic disease and cancer.

Independent Directors

The Clinical Operations and Management team at Galectin Therapeutics is responsible for overseeing the planning, execution, and management of clinical trials for drug candidates targeting fibrotic disease and cancer. This team ensures that all clinical activities comply with regulatory requirements and are carried out efficiently. Members coordinate between various departments, manage project timelines, ensure data integrity, and contribute to strategic planning to bring innovative therapies to market.

Clinical Operations and Management

This department oversees governance and administrative functions related to the board of directors.

Board Administration

This department provides strategic direction and oversight for the organization's overall operations and governance.

Executive Leadership

This department manages financial operations and provides administrative support to ensure smooth organizational functions.

Finance and Administration

The Leadership Team at Galectin Therapeutics is responsible for strategic decision-making and guiding the company's vision to advance innovative therapies targeting galectin proteins for fibrotic diseases and cancer. This team, composed of top executives including the CEO, CFO, and Chief Medical Officer, oversees clinical development, financial health, and operational excellence, ensuring the alignment of scientific endeavors with business objectives to drive the company's growth and mission.

Galectin Therapeutics

Org chart

Board & advisors

Teams

Independent Directors

Clinical Operations and Management

Board Administration

Executive Leadership

Finance and Administration

Leadership Team

Offices

Galectin Therapeutics

Org chart

Board & advisors

Teams

Independent Directors

Clinical Operations and Management

Board Administration

Executive Leadership

Finance and Administration

Leadership Team

Offices

Related companies